Co-chair 1: Good morning, we will start. Let me call the 4th round table on the world drug problem. Let me take this opportunity to cordially welcome all of you to the deliberation today. The round-table is entitled: Cross-cutting issues, new challenges, threats and realities. I read Forbes magazine last night, it was stressed last …
Malaysia
UNGASS roundtable 3: Cross-cutting issues: Drugs and human rights, youth, women, children and communities
GRULAC – H.E. Ana H. Chacon, Vice President, Costa Rica – Costa Rica never saw drug use as a crime, but as a problem to be dealt with from a health perspective. We didn’t put people in prison for using drugs. In 2002, passed a law to use 60% of resources from seized drugs to …
Thirtieth special session of the General Assembly on the world drug problem (2nd plenary meeting)
The full statements delivered by member states during the UNGASS general debate are available here. Chair: We will resume the agenda. India: This is an Historic special session. We are meeting after 2009 political declaration, just months after we adopted SDPs. The Drug problem impacts our ability to achieve this agenda. The three conventions have …
General Assembly: Thirtieth special session of the General Assembly on the world drug problem (Opening segment)
The full statements delivered by member states during the UNGASS general debate are available here. Mogens Lykketoft: Ladies and gentlemen, I think for the election as President of this special session. Let me express my condolences to the delegations of Ecuador and Japan whose countries have been hit by deadly earthquakes. It is an honour …
UNGASS special segment, third meeting
El Salvador: Thanks board. CND is a path to UNGASS and an important opportunity. Current conventions and commitments are the reference point, but must be flexible. The main pillar of our policy decisions is the three conventions. The socioeconomic element is an important part of our agenda on the road to UNGASS. The sustainable development …
CND Day 1 – Agenda item 6(b): Change in the scope of control of substances
Commission will identify the notifications in the order they were received. Begin with mephedrone recommended by the UK. Then will look at ketamine recommended by China. Then will look at reocmmendations from the WHO including (a) AH-7921 should be placed in Schedule I of the 1961 Convention; (b) gamma-Butyrolactone (GBL), 1,4-butanediol, 25B-NBOMe (2C-B-NBOMe), 25C-NBOMe (2C-C-NBOMe) …